On Aug. 18, 2022, Novavax announced that New Zealand’s Medsafe had granted expanded provisional approval for Nuvaxovid (NVX-CoV2373)…
On Feb. 3, 2022, Novavax announced that New Zealand’s Medsafe had been granted provisional approval of NVX-CoV2373, Novavax’…
On Nov. 3, 2021, Novavax announced the company had filed for provisional approval of the vaccine to the…
On Dec. 16, 2020, Novavax announced an Advance Purchase Agreement with the government of New Zealand for the…
On Apr. 29, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine announced that a…